How to Cure Anorexia: Treatment and Recovery Options

Full recovery from anorexia is possible. Learn how nutrition, therapy, and the right level of care work together to support lasting healing.

Anorexia nervosa does not have a single cure in the way an infection has an antibiotic, but it is treatable, and full recovery is a realistic outcome for many people. Treatment typically involves a combination of medical stabilization, structured psychotherapy, nutritional rehabilitation, and sometimes medication. The process is rarely quick, and relapse rates over the long term run around 40 to 50 percent, which means sustained support matters as much as the initial intervention. What follows is a practical walk through the treatment landscape, from the first days of refeeding through years of maintaining recovery.

Why Anorexia Is Not a Simple Willpower Problem

One of the most persistent misconceptions about anorexia is that it boils down to a choice about eating. Research over the past two decades has made it clear that the disorder has deep biological roots. A large genome-wide study identified eight genetic risk loci and found that the genetic architecture of anorexia overlaps with psychiatric conditions, metabolic traits, and physical activity patterns, leading the researchers to describe it as a “metabo-psychiatric disorder.” Brain imaging studies add another layer: people with anorexia show altered activity in reward-processing circuits, particularly the anterior cingulate cortex and striatum, in ways that can make self-starvation feel rewarding rather than punishing. These neurobiological differences don’t just make anorexia harder to understand from the outside; they also help explain why malnutrition itself can deepen the disorder by further altering the brain circuits that drive the illness.

Understanding this biology matters for treatment because it explains why “just eat more” is not a viable prescription, and why the recovery process requires careful medical and psychological intervention working in tandem.

Medical Stabilization and Refeeding

For anyone who is significantly underweight, the first priority is physical safety. The body adapts to starvation in ways that make the reintroduction of food genuinely dangerous if done carelessly. Refeeding syndrome is the main risk. When a malnourished body suddenly switches from starvation mode to a fed state, it can trigger electrolyte crashes, particularly drops in phosphorus, potassium, and magnesium, along with vitamin depletion and fluid imbalances that can cause cardiac arrhythmias and organ dysfunction.

For years, the standard approach was to start very cautiously with low calories and increase slowly. More recent evidence has shifted this thinking. A systematic review found that higher-calorie refeeding has not been associated with increased risk of refeeding syndrome when done under close medical monitoring with electrolyte correction. A randomized trial comparing higher-calorie and lower-calorie refeeding in hospitalized adolescents found that the higher-calorie group achieved medical stability about three days earlier, gained more weight, and had a hospital stay roughly four days shorter, with no increase in safety events and no cases of clinical refeeding syndrome. The one-year follow-up showed that remission and rehospitalization rates were similar between the two groups, which the researchers interpreted as supporting the higher-calorie approach since it got patients to stability faster without any long-term cost.

The practical takeaway is that refeeding should be done in a medical setting where electrolytes can be monitored and corrected, but the old ultra-cautious calorie protocols are giving way to faster approaches that reduce hospital time and costs.

Psychotherapy for Adolescents

For teenagers with anorexia, the treatment with the strongest track record is family-based treatment, often called the Maudsley approach. Rather than placing all the therapeutic burden on the adolescent, this model puts parents in charge of refeeding and weight restoration in the early phase, then gradually hands control back to the teenager as they recover. Multiple studies support its effectiveness, especially when the illness has been present for less than three years, with benefits shown to endure at five-year follow-up.

There have also been experiments with augmenting the standard model. One trial tested adding parent-to-parent consultation, where families further along in the process coached newer families, and found it led to a small but significant increase in the rate of weight restoration. That peer-support element can be especially valuable because caring for a child with anorexia is exhausting and isolating, and knowing that another family has been through it provides a kind of practical encouragement that clinicians alone cannot offer.

Psychotherapy for Adults

Adult treatment is trickier. By the time someone has been living with anorexia for years, the illness tends to be more entrenched, and family-based approaches designed for adolescents don’t translate directly. The most studied individual therapy for adult anorexia is enhanced cognitive behavioral therapy, known as CBT-E. A UK-Italy study of CBT-E for adults with anorexia found that about two-thirds completed the full 40 weeks of treatment, and among those completers, the average weight gain was roughly seven and a half kilograms. Over 60 percent reached a body mass index at or above 18.5, and nearly 90 percent had minimal residual eating disorder thoughts and behaviors by the end. A separate study in a routine clinical setting also found that CBT-E produced greater weight regain compared to treatment as usual.

CBT-E is not the only option. A large randomized trial (the ANTOP study) compared CBT-E, focal psychodynamic therapy, and optimized treatment as usual in adults with anorexia. Focal psychodynamic therapy, which focuses on the emotional and relational issues beneath the eating disorder, had an advantage in terms of overall recovery rates at 12-month follow-up, while CBT-E led to faster weight gain and quicker improvement in eating disorder-specific symptoms. The fact that different therapies have different strengths is worth knowing if you’re choosing a treatment path. Someone who needs rapid weight restoration might benefit most from CBT-E, while someone whose emotional patterns are central to maintaining the disorder might do better with psychodynamic work.

What Medications Can and Cannot Do

There is no pill that treats anorexia the way medications treat depression or anxiety. Controlled trials of medications given during the underweight phase have overwhelmingly shown no benefit over placebo. This includes SSRIs, the class of antidepressants most commonly prescribed. A review of the evidence concluded that SSRIs lack efficacy during the acute treatment phase but may help with relapse prevention and psychiatric symptoms once weight has been restored. Part of the reason is thought to be biological: when the brain is malnourished, it doesn’t have the raw materials to respond normally to serotonin-targeting drugs.

The one medication that has shown modest benefit for weight gain is olanzapine, an atypical antipsychotic. A meta-analysis found that olanzapine produced a mean BMI increase of about 0.67 kg/m² more than placebo. A randomized trial found that olanzapine led to faster weight gain and earlier achievement of target BMI, along with a decrease in obsessive symptoms, with no difference in side effects compared to placebo. Doses in studies have ranged from 2.5 to 15 mg daily. These effects are real but small. Olanzapine is best understood as a tool that can help nudge weight restoration along, especially when obsessive thinking about food and body image is intense, not as a standalone treatment.

Relapse and What Predicts It

Even after successful treatment, anorexia has a high rate of return. A meta-analysis found that relapse rates over follow-up periods of up to ten years run around 40 to 50 percent. A prospective study found that 41 percent of participants relapsed within one year, with the highest risk window falling between four and nine months after treatment ended. That window is consistent with findings from a relapse prevention program where no full relapses occurred in the first four months but the peak risk was between months four and sixteen.

The factors linked to higher relapse risk include having the binge-purge subtype of anorexia (as opposed to the restricting subtype), more severe eating disorder symptoms at the start of treatment, the presence of co-occurring psychiatric conditions, and declining motivation to recover during treatment. On the protective side, higher body weight and BMI at the end of treatment, greater motivation, and better treatment response were all associated with lower odds of relapse. The clinical implication is straightforward: treatment that achieves robust weight restoration, not just minimal improvement, and that actively works on sustaining motivation gives the best shot at staying well.

What Recovery Actually Means

Researchers have struggled to agree on a single definition of recovery from anorexia, which makes outcome statistics difficult to compare across studies. One influential framework identifies three dimensions: physical recovery (reaching a healthy BMI), behavioral recovery (absence of restricting, bingeing, or purging), and psychological recovery (eating disorder thoughts and distress falling within the normal range). Only people who meet all three criteria are classified as “fully recovered” in that model, which helps explain why reported recovery rates vary so widely depending on which definition a study uses.

A systematic review and qualitative meta-analysis of what patients and clinicians consider fundamental to recovery found that it goes beyond the absence of symptoms. The most frequently mentioned criteria included self-acceptance, positive relationships, personal growth, decreased eating disorder behavior and thinking, resilience, and autonomy. Patients themselves tend to define recovery in broader terms than clinicians do, emphasizing identity, quality of life, and emotional regulation alongside the physical benchmarks. This gap matters. If a treatment plan focuses only on weight and eating behaviors without addressing the psychological dimension, the person may look recovered on paper while still feeling trapped.

Recovering the Body Beyond Weight

Weight restoration is the foundation, but the body has to heal in ways that go beyond the number on the scale. Two areas that often get overlooked are bone health and gut function.

Anorexia causes significant bone loss. Weight gain has the strongest proven impact on bone mineral density, and restoration of normal hormonal function (particularly estrogen in women) appears to help independently. Medications used for osteoporosis in other populations, such as bisphosphonates and teriparatide, are being explored and may decrease fracture risk and improve bone density, although long-term data in anorexia patients specifically are still limited. If you have been significantly underweight for an extended period, a bone density scan is a reasonable conversation to have with your treatment team.

Gastrointestinal symptoms are another persistent complaint during recovery. Nutritional rehabilitation tends to improve lower GI symptoms like constipation, but upper GI symptoms like bloating, abdominal fullness, and a feeling of distension often linger even as weight normalizes. Abdominal pain and incomplete evacuation can remain more common than in people without a history of anorexia. A diet with adequate fiber and fat may help create better conditions for the gut microbiome to recover, though the research in this specific population is still in its early stages. The important thing to know is that these symptoms are normal during recovery and do not mean something is wrong with the treatment plan.

Emerging Treatments

Two experimental approaches have generated interest in recent years, though neither is ready for clinical use.

Psilocybin-assisted psychotherapy is being explored for treatment-resistant anorexia. A phase 1, open-label feasibility study in women with anorexia found that psilocybin was safe and tolerable, with all adverse events being mild and transient. Two participants developed asymptomatic low blood sugar that resolved within 24 hours. No concerning changes were seen in heart rhythm, vital signs, or suicidality. A systematic review concluded that early evidence suggests psilocybin might be safe and well-tolerated, but the results are too preliminary to draw conclusions about effectiveness, and larger trials are needed. Additional trials are being registered, including one in Australia specifically targeting treatment-resistant anorexia.

Transcranial magnetic stimulation, a non-invasive brain stimulation technique already used for depression, is also being evaluated for anorexia. Research in this area is early, with a systematic review and meta-analysis describing it as “promising” but not yet established. Neither psilocybin nor TMS should be sought as an alternative to established treatments right now, but they represent genuine areas of active investigation rather than fringe ideas.

When Anorexia Becomes Long-Standing

A subset of people develop what clinicians call severe and enduring anorexia nervosa, generally defined as having the illness for many years without sustained response to standard treatments. For this group, the conventional recovery-focused approach can feel coercive and demoralizing after repeated failed attempts. A growing conversation in the field centers on harm reduction as a complementary framework. Borrowed from substance use treatment, harm reduction in this context prioritizes quality of life, personal autonomy, and minimizing medical danger rather than demanding full weight restoration as the only acceptable outcome.

This does not mean giving up. It means adjusting treatment goals so that a person who has been gravely ill for a decade is supported in staying as medically stable as possible, maintaining social connections, and achieving small improvements rather than being told they must either pursue full recovery or receive nothing. The idea has generated both enthusiasm and debate. Critics worry that labeling anorexia as “enduring” too early could become a self-fulfilling prophecy. Proponents argue that forcing repeated inpatient stays on someone who has not responded is ethically questionable and practically ineffective. Most clinicians in this area frame harm reduction as a phase of treatment rather than a permanent endpoint.

Access Barriers and Disparities

Even when effective treatments exist, getting access to them is profoundly unequal. A retrospective study of youth with eating disorders found that patients with public insurance were about a third as likely to receive recommended treatment as those with private insurance. Latinx and Asian patients were roughly half as likely to receive recommended treatment compared to White patients, even after adjusting for clinical severity and demographics. Among college students, those from more affluent backgrounds had higher odds of both perceiving a need for treatment and actually receiving it.

A survey of treatment seekers found that financial barriers, including lack of insurance coverage, were the most frequently reported obstacle. People from historically underrepresented groups reported more barriers across multiple dimensions, including finances, geography, being identified as having an eating disorder in the first place, sociocultural factors, and treatment quality. Men face their own set of access challenges. Anorexia in males is under-recognized by both patients and clinicians, partly because the disorder is stereotyped as a condition affecting young White women. A scoping review highlighted the need for male-specific treatment approaches and better screening by primary care providers.

Virtual and Remote Treatment Options

The growth of telehealth has opened up treatment possibilities, particularly for families in rural areas or those unable to attend weekly in-person sessions. A feasibility trial compared family-based treatment delivered by videoconference with a guided self-help version of FBT and found that both produced medium to large improvements in weight and eating disorder symptoms, with gains maintained at a three-month follow-up. The guided self-help version was more efficient in terms of outcomes per hour of therapist time, though clinicians reported feeling less comfortable delivering it compared to standard video sessions. Virtual treatment is not a perfect substitute for in-person care, especially when medical monitoring is needed, but it meaningfully lowers the barrier for families who would otherwise get no specialized treatment at all.